Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+7028Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+7796Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+7938Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+9592Peak area normalizedmale diabetic Neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+10000Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+10558Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+10708Peak area normalizedmale diabetic no neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+11559Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+13678Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+17635Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+18262Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+18427Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+18575Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEORNITHINE (M+H)+35745Peak area normalizedfemale diabetic no neuropathy

Return to search page
  logo